Income Statement
Revenue$2.8B
Gross Profit$1.8B
Operating Income$855.3M
EBITDA$1.1B
Net Income$821.5M
ISRG
Intuitive Surgical, Inc.
NMSSector: HealthcareIndustry: Medical Instruments & Supplies
Valuation
Market Cap
$141.73B
Enterprise Value
$137.92B
P/E
48.6
TTMFwd P/E
34.0
1YP/B
8.1
P/S
13.4
TTMPEG
2.11
EV/EBITDA
35.5
EV/Revenue
13.0
FCF Yield
2.1%
EPS (TTM)
$8.24
Fwd EPS
$11.79
Book Value
$49.31
Market Data
Beta
1.45
Avg Volume
2.3M
Shares Out
354.2M
Float
352.1M
Short % Float
2.1%
Insider %
0.6%
Institutional %
89.3%
D/E
—
Current Ratio
4.6
ROE
17.2%
ROA
10.2%
Rev Growth
23.0%
Net Inc Growth
18.8%
Profit Margin
28.2%
Op Margin
30.9%
Gross Margin
66.3%
Total Cash
$4.52B
Total Debt
$0
Financials
Latest period financial summary
Balance Sheet
Total Assets$20.1B
Current Assets$8.8B
Cash$2.0B
Total Liabilities$2.5B
Equity$17.6B
Total Debt—
Cash Flow
Operating CF$911.9M
Investing CF$-914.5M
Financing CF$-1.4B
Free Cash Flow$808.6M
Financial Trends
Revenue$2.8B
2022/122026/3
Net Income$821.5M
2022/122026/3
EBITDA$1.1B
2022/122026/3
Free Cash Flow$808.6M
2022/122026/3
Period Analysis
Margins & Ratios
| Metric | 2021/12 | 2022/12 | 2023/12 | 2024/9 | 2024/12 | 2025/3 | 2025/6 | 2025/9 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $6.2B | $7.1B | — | $8.4B | $2.3B | $2.4B | $2.5B |
| Gross Margin | — | +67.4% | +66.4% | — | +67.5% | +64.7% | +66.3% | +66.4% |
| EBITDA Margin | — | +31.2% | +31.2% | — | +34.1% | +32.3% | +36.5% | +36.7% |
| Operating Margin | — | +25.3% | +24.8% | — | +28.1% | +25.7% | +30.5% | +30.3% |
| Net Margin | — | +21.3% | +25.2% | — | +27.8% | +31.0% | +27.0% | +28.1% |
| Current Ratio | — | 4.40 | 4.76 | — | 4.07 | 4.98 | 5.17 | 4.73 |
| Debt / Equity | — | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — |
| ROE | — | +11.9% | +13.4% | — | +14.1% | +4.1% | +3.7% | +4.1% |
| ROA | — | +10.2% | +11.6% | — | +12.4% | +3.6% | +3.3% | +3.6% |
| Leverage | — | 0.14 | 0.13 | — | 0.12 | 0.10 | 0.11 | 0.12 |
Company Profile
Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Employees
17K
Location
Sunnyvale, CA
Country
US
Golden Bazaar VerifiedUpdated: Jun 25, 2026Data Source: Golden Bazaar Verified · Updated: Jun 25, 2026
Sector Peers
Comparison Screen →Healthcare
Compare with similar companies in the same sector.
This page is prepared by Golden Bazaar using publicly available data. Not investment advice.